Attendees to Learn Real-World Applications of Cancer Immunotherapy, American Society of Clinical Oncology’s 2015 Cancer Advance of the Year
 
 
PLAINSBORO, N.J. (February 26, 2016) — Physicians’ Education Resource^®, LLC (PER^®), the “go-to” source for oncology and hematology continuing medical education, today announced that the first annual International Congress on Immunotherapies in Cancer^™: Focus on Practice-Changing Application will be held December 10 at the Crowne Plaza^® Times Square Manhattan, New York.
 
“Immunotherapies are changing the entire treatment landscape of oncology care, with data being unveiled almost daily on what their potential is and how they are helping cancer patients in virtually all types of solid and liquid tumors,” explained PER^® President Phil Talamo. “Their emergence is moving so quickly that ASCO named cancer immunotherapy as its 2015 Advance of the Year. Unfortunately, there has not been a meeting or gathering of experts that truly focuses on how to actually use these new agents in the clinic, how to manage patients while on them and how to maximize their impact during therapy. This meeting fills that need while providing attendees with data from leading experts who will discuss and distill the information into clinical pearls that attendees can take home and directly apply to improving potential patient outcomes.”
 
The International Congress on Immunotherapies in Cancer: Focus on Practice-Changing Application will be chaired by Naiyer Rizvi, M.D., director of thoracic oncology and director of immunotherapeutics at Columbia University Medical Center’s Division of Hematology/Oncology, and Antoni Ribas, M.D., Ph.D., professor of medicine, professor of surgery and professor of molecular and medical pharmacology at UCLA. He is also the director of the Tumor Immunology Program at UCLA’s Jonsson Comprehensive Cancer Center and chair of the Melanoma Committee at Southwest Oncology Group (SWOG). Both doctors are internationally recognized leaders in the treatment of cancer and immunotherapy drug development.
 
“We’re uncovering new opportunities for immuno-oncology agents almost every day, which is literally shifting the paradigm in cancer treatment,” said Dr. Rizvi. “This meeting will not only update physicians on the latest data, but it will also guide them on what they really need to know while using an immunotherapy in cancer treatment, including the key aspects in treatment decision making, interdisciplinary care, patient management and counseling, and other important real-world strategies. It will be a very unique meeting that fills a necessary void.”
 
Dr. Ribas added, “As a congress chairperson and attendee, it’s exciting to bring together the leading experts in immunotherapy across several different tumor types as they drive the understanding of how, when and for which patients immunotherapies are an option. To have all of this knowledge in one location at one time will surely lead to amazing discussions, learning opportunities and shared experiences of treating patients.”
 
More information about the International Congress on Immunotherapies in Cancer^™: Focus on Practice-Changing Application can be found at www.gotoper.com.
 
About Physicians’ Education Resource^® (PER^®)
As a leader in continuing medical education (CME) for nearly 20 years, Physicians’ Education Resource^® (PER^®) educates more oncologists and hematologists through live annual CME-certified conferences than any other medical education provider in the United States. PER^® provides high-quality, evidence-based, CME-certified activities that translate the science of oncology into the art of patient care by featuring leading national and international faculty that focus on practice-changing advances that help the busy oncologist stay up-to-date with cutting-edge oncology knowledge and treatments. Accredited by the Accreditation Council for Continuing Medical Education, PER^® serves the broader oncology health care community, including physicians, nurses, nurse practitioners, physician assistants and pharmacists. PER^® is part of Michael J. Hennessy Associates, Inc., a full-service health care communications company offering education, research and medical media.
 
# # #
 
Media Contact:
Michael J. LaCosta
Executive Director of Public Relations
[email protected]
551-655-3718